Trade Ideas

Actionable trade ideas with defined risk and time horizons.

Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.

Articles

10,762 total articles

Alcon: Buy a Durable Ophthalmology Leader Trading Near Fair Value

Alcon: Buy a Durable Ophthalmology Leader Trading Near Fair Value

Alcon is a global leader in ophthalmic surgical equipment and vision care products trading at roughly $74.25 and a market cap near $37 billion. With modest leverage, improving technicals, and secular tailwinds in ophthalmology, the stock looks priced close to intrinsic value. We recommend buying at current levels with a long-term horizon and tight …

Energy Fuels: Proof of Growth — Time to Upgrade to Long Bias

Energy Fuels: Proof of Growth — Time to Upgrade to Long Bias

Energy Fuels has moved from promise to production. Recent commercial rare-earth output, a conditional $725M DoD loan commitment, and the $1.9B Vacuumschmelze acquisition create a clearer path to earnings and vertical integration. The shares are volatile and still loss-making, but the risk/reward now favors a long position with a well-defined stop a…

Planet Labs: The Q2 Proof Point That Needs to Arrive to Earn Its Multiple

Planet Labs: The Q2 Proof Point That Needs to Arrive to Earn Its Multiple

Planet Labs trades near $25 with a market cap of about $8.8B and a stretched price-to-sales multiple (~26x). The company has visible growth - recent revenue prints near $94M and a reported ~$900M backlog - but margins, free cash flow conversion, and dilution risk are the items investors need to see improve in the Q2 report to defend the current val…

AmpliTech: Reset Expectations, Compelling Risk-Adjusted Entry Near $4

AmpliTech: Reset Expectations, Compelling Risk-Adjusted Entry Near $4

AmpliTech (AMPG) has legitimately advanced its Open RAN radios and won technical validations, but recent financing and mixed cash flow argue for tempered revenue expectations. At roughly $4.06 today the shares offer a better risk/reward than during the June rally. This is a tactical mid-term long idea that leans on improving order flow, an authoriz…

Chord Energy: Cash Flow Strength Makes Buybacks a Credible Growth Engine

Chord Energy: Cash Flow Strength Makes Buybacks a Credible Growth Engine

Chord Energy's balance sheet and free cash flow profile make a buyback-and-FCF-per-share thesis viable. With free cash flow near $1.19B, modest leverage, and a sub-9x P/E, the stock trades at a valuation that gives management room to repurchase shares while still funding dividends and selective reinvestment. I recommend a position-sized long with a…

Nebius Breakout: Pricing Power Rewrites the Growth Story

Nebius Breakout: Pricing Power Rewrites the Growth Story

Nebius (NBIS) just re-priced. Strong net-loss improvement, $236M EBITDA, larger enterprise deals and an asset-light pivot have the market re-assessing growth economics. At a market cap of ~$69.9B the stock is richly valued, but a discrete set of catalysts and technical momentum create a tradeable long setup with defined risk controls over the next …

Tariffs, Contracts and Momentum: Why RCAT's Rally Still Has Room to Run

Tariffs, Contracts and Momentum: Why RCAT's Rally Still Has Room to Run

Red Cat (RCAT) has a string of positive government wins and a macro policy tailwind from new tariffs that make a mid-term long trade attractive despite stretched valuation and negative cash flow. Entry at $11.12, stop at $9.25, target $16.50 over a mid-term (45 trading days) horizon. Risk management and close monitoring of program milestones are cr…

TTM Technologies: From Boring PCB Maker to AI-Fueled Growth Play

TTM Technologies: From Boring PCB Maker to AI-Fueled Growth Play

TTM Technologies has pivoted from cyclical PCB manufacturing to being a direct beneficiary of AI infrastructure buildouts. Recent results and Europe-focused acquisitions support revenue acceleration, while valuation still leaves room for upside if growth sustains. This trade idea outlines an actionable entry, stop, and target with clear catalysts a…

Buy Micron Now: KOSPI-Driven Panic Is a Better Entry Than a Warning

Buy Micron Now: KOSPI-Driven Panic Is a Better Entry Than a Warning

Micron (MU) is a buy on pullback. The stock trades at $972.98 after a sector wobble linked to KOSPI weakness. Fundamentals - $26.2B free cash flow, EPS $44.69, ROE 50% and a $1.1T market cap - support a long trade to $1,250 over the next 46-180 trading days. Entry $975, stop $820, target $1,250. Risk is real but manageable with tight sizing.

Church & Dwight: Buy for Volume-Led Growth and Margin Rebound

Church & Dwight: Buy for Volume-Led Growth and Margin Rebound

Church & Dwight ($101.33) offers a pragmatic buy: secular demand in laundry and sexual health categories, recent volume recovery, a conservative balance sheet (debt/equity ~0.52) and improving margins underpin a mid-term swing trade. Entry $101.00, target $110.00, stop $94.00 for a 45-trading-day plan with a medium risk profile.

Ituran: Buy the Dip — Q2 Cash Flow and Dividends Validate the Rebound

Ituran: Buy the Dip — Q2 Cash Flow and Dividends Validate the Rebound

Ituran’s combination of strong cash generation, a clean balance sheet and an active dividend policy argues for buying the recent dip. The business remains cash-rich with no bank debt, free cash flow of roughly $49M and recurring payouts that show management confidence. Technicals suggest room to run toward the 52-week high while downside can be con…